Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor
  2. Zhang, Xiyuan; Lou, Hannah E; Gopalan, Vishaka; Liu, Zhihui; Jafarah, Hilda M; Lei, Haiyan; Jones, Paige; Sayers, Carly M; Yohe, Marielle E; Chittiboina, Prashant; Widemann, Brigitte C; Thiele, Carol J; Kelly,Michael; Hannenhalli, Sridhar; Shern, Jack F
  3. Cell Reports. 2022, Sep 20; 40(12): 111363.
  1. 2.   LSH mediates gene repression through macroH2A deposition
  2. Ni,Kai; Ren, Jianke; Xu,Xiaoping; He,Yafeng; Finney, Richard; Braun, Simon M. G.; Hathaway, Nathaniel A.; Crabtree, Gerald R.; Muegge,Kathrin
  3. NATURE COMMUNICATIONS. 2020, NOV 6; 11(1):
  1. 3.   An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
  2. Crea, F.; Fornaro, L.; Paolicchi, E.; Masi, G.; Frumento, P.; Loupakis, F.; Salvatore, L.; Cremolini, C.; Schirripa, M.; Graziano, F.; Ronzoni, M.; Ricci, V.; Farrar, W. L.; Falcone, A.; Danesi, R.
  3. Annals of Oncology. 2012, May; 23(5): 1207-1213.
  1. 4.   PRC2 directly methylates GATA4 and represses its transcriptional activity
  2. He, A. B.; Shen, X. H.; Ma, Q.; Cao, J. J.; von Gise, A.; Zhou, P. Z.; Wang, G.; Marquez, V. E.; Orkin, S. H.; Pu, W. T.
  3. Genes & Development. 2012, Jan; 26(1): 37-42.
  1. 5.   Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS
  2. Tao, Y. G.; Liu, S.; Briones, V.; Geiman, T. M.; Muegge, K.
  3. Nucleic Acids Research. 2011, Dec; 39(22): 9508-9520.
  1. 6.   The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation
  2. Weissman, A. M.; Shabek, N.; Ciechanover, A.
  3. Nature Reviews Molecular Cell Biology. 2011, Sep; 12(9): 605-620.
  1. 7.   Faithful Markers of Circulating Cancer Stem Cells: Is CD133 Sufficient for Validation in Clinics?
  2. Crea, F.; Fornaro, L.; Masi, G.; Falcone, A.; Danesi, R.; Farrar, W.
  3. Journal of Clinical Oncology. 2011, Sep; 29(25): 3487-3488.
  1. 8.   Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy
  2. Sasaki, D.; Imaizumi, Y.; Hasegawa, H.; Osaka, A.; Tsukasaki, K.; Choi, Y. L.; Mano, H.; Marquez, V. E.; Hayashi, T.; Yanagihara, K.; Moriwaki, Y.; Miyazaki, Y.; Kamihira, S.; Yamada, Y.
  3. Haematologica-the Hematology Journal. 2011, May; 96(5): 712-719.
  1. 9.   BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer
  2. Crea, F.; Serrat, M. A. D.; Hurt, E. M.; Thomas, S. B.; Danesi, R.; Farrar, W. L.
  3. International Journal of Cancer. 2011, Apr; 128(8): 1946-1954.
  1. 10.   Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma
  2. Teider, N.; Scott, D. K.; Neiss, A.; Weeraratne, S. D.; Amani, V. M.; Wang, Y. F.; Marquez, V. E.; Cho, Y. J.; Pomeroy, S. L.
  3. Neuro-Oncology. 2010, Dec; 12(12): 1244-+.
  1. 11.   miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
  2. Smits, M.; Nilsson, J.; Mir, S. E.; van der Stoop, P. M.; Hulleman, E.; Niers, J. M.; Hamer, P.; Marquez, V. E.; Cloos, J.; Krichevsky, A. M.; Noske, D. P.; Tannous, B. A.; Wurdinger, T.
  3. Oncotarget. 2010, Dec; 1(8): 710-720.
  1. 12.   TNF/p38 alpha/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration
  2. Palacios, D.; Mozzetta, C.; Consalvi, S.; Caretti, G.; Saccone, V.; Proserpio, V.; Marquez, V. E.; Valente, S.; Mai, A.; Forcales, S. V.; Sartorelli, V.; Puri, P. L.
  3. Cell Stem Cell. 2010, Oct; 7(4): 455-469.
  1. 13.   Altering a Histone H3K4 Methylation Pathway in Glomerular Podocytes Promotes a Chronic Disease Phenotype
  2. Lefevre, G. M.; Patel, S. R.; Kim, D.; Tessarollo, L.; Dressler, G. R.
  3. Plos Genetics. 2010, Oct; 6(10): 15.
  1. 14.   Epigenetic Analysis of KSHV Latent and Lytic Genomes
  2. Toth, Z.; Maglinte, D. T.; Lee, S. H.; Lee, H. R.; Wong, L. Y.; Brulois, K. F.; Lee, S.; Buckley, J. D.; Laird, P. W.; Marquez, V. E.; Jung, J. U.
  3. Plos Pathogens. 2010, Jul; 6(7): 17.
  1. 15.   EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
  2. Suva, M. L.; Riggi, N.; Janiszewska, M.; Radovanovic, I.; Provero, P.; Stehle, J. C.; Baumer, K.; Le Bitoux, M. A.; Marino, D.; Cironi, L.; Marquez, V. E.; Clement, V.; Stamenkovic, I.
  3. Cancer Research. 2009, Dec; 69(24): 9211-9218.
  1. 16.   Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases
  2. Hong, S. H.; Cho, Y. W.; Yu, L. R.; Yu, H.; Veenstra, T. D.; Ge, K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Nov; 104(47): 18439-18444.
  1. 17.   Lsh controls Hox gene silencing during development
  2. Xi, S. C.; Zhu, H. M.; Xu, H.; Schmidtmann, A.; Geiman, T. M.; Muegge, K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Sep; 104(36): 14366-14371.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel